Gut-Brain Axis Newsletter
Issue #38May 25, 20267 studies

Stroke patients' gut bacteria accelerated Alzheimer's pathology when transplanted into mice

This week brought fascinating insights into how our gut and brain communicateβ€”from stroke survivors' altered microbiomes to specific bacteria that might protect against Parkinson's disease. Here's what researchers discovered about the gut-brain connection.

🧠 Stroke survivors' gut bacteria fast-tracked Alzheimer's in mice

  • Fecal transplants from stroke patients into young Alzheimer's model mice accelerated tau phosphorylation and increased neuroinflammation compared to transplants from healthy donors
  • The stroke-derived microbiota caused persistent donor-specific gut dysbiosis and broad metabolic changes affecting redox balance, nucleotide metabolism, and energy pathways in both gut and brain tissue
  • Single-cell spatial analysis revealed widespread brain changes including glial activation, impaired neuron-glia communication, and disrupted mitochondrial and inflammatory pathways across cortical and hippocampal regions

Why it matters: This provides direct experimental evidence that post-stroke gut dysbiosis may mechanistically contribute to the elevated Alzheimer's risk seen in stroke survivors, highlighting the gut-brain axis as a potential target for preventing post-stroke dementia.

πŸ₯‰ Top 5% journal πŸ”— J Cereb Blood Flow Metab Journal Article πŸ—“οΈ May 20

Key Findings

🦠 High-altitude bacteria produced dopamine and improved Parkinson's symptoms

  • Enterococcus hirae QT4713, isolated from the Qinghai-Tibet Plateau at 4,713 meters altitude, contains genes that convert L-tyrosine to dopamine in lab tests
  • In MPTP-induced Parkinson's mice, this strain alleviated motor and gastrointestinal dysfunction, reduced oxidative damage, and preserved dopaminergic neurons
  • The bacteria increased dopamine and tyrosine levels in the striatum while reshaping gut microbial composition and promoting beneficial short-chain fatty acid production
πŸ’‘ A naturally occurring gut microbe may offer a novel approach to supporting dopamine production in Parkinson's disease.
πŸ₯‰ Top 5% journal πŸ”— NPJ Parkinson's disease Journal Article πŸ—“οΈ May 19

🧬 Genetic analysis identified protective gut bacteria for Parkinson's

  • Mendelian randomization analysis of genome-wide data found that genus Sellimonas was a robust protective factor for Parkinson's disease (OR = 0.784, 95% CI: 0.703-0.873)
  • The metabolite methylsuccinate emerged as a robust risk factor (OR = 1.197, 95% CI: 1.118-1.282) after correction for multiple testing
  • Exploratory analysis suggested a pathway where Bacillales bacteria may protect against Parkinson's by reducing methylsuccinate levels, accounting for 12.5% of the protective effect
πŸ’‘ Genetic evidence suggests specific gut bacteria and their metabolites may causally influence Parkinson's disease risk.
πŸŽ–οΈ Top 10% journal πŸ”— Current neuropharmacology Journal Article πŸ—“οΈ May 21

πŸ§ͺ Butyrate enhanced memory formation differently in male and female mice

  • A 40-minute exposure to 3 ΞΌM butyrate enhanced long-term potentiation in hippocampal slices from both male and female mice
  • The memory enhancement in females was mediated by free fatty acid receptor 3 (FFAR3), as blocking this receptor with Ξ²-Hydroxybutyrate eliminated butyrate's effects in females but not males
  • Acetate and propionate, two other major gut-derived short-chain fatty acids, showed no significant effects on memory formation
πŸ’‘ Sex differences in how gut-derived butyrate affects brain plasticity may help explain why men and women respond differently to microbiome-based interventions.
πŸ”— Journal of neurochemistry Journal Article πŸ—“οΈ May 21

πŸ”¬ Probiotic metabolites reversed stress-induced memory problems

  • Postbiotics from Lactobacillus rhamnosus and Bifidobacterium longum given to chronically stressed mice for 8 weeks significantly improved performance on spatial, recognition, and inhibitory memory tests
  • Bifidobacterium longum postbiotics showed the most robust effects, with treated mice showing reduced escape times in water maze tests and improved object discrimination
  • The cognitive improvements correlated with increased expression of AKT and Arc genes in the hippocampus, which are linked to learning and memory formation
πŸ’‘ Non-living bacterial metabolites may offer therapeutic benefits for stress-related cognitive decline without requiring live probiotics.
Top 20% journal πŸ”— Scientific reports Journal Article πŸ—“οΈ May 19

🧠 Gut bacteria types linked to brain function and memory in 510 people

  • Analysis of gut bacteria in 510 healthy young adults revealed significant differences in brain activity in parietal and occipital cortices across Bacteroides, Prevotella, and Ruminococcaceae enterotypes
  • These brain functional differences correlated with both episodic and working memory performance
  • Statistical mediation analysis showed that brain function mediated the relationship between gut bacteria type and memory abilities
πŸ’‘ Different gut bacterial communities may influence cognitive abilities through measurable changes in brain activity patterns.
πŸŽ–οΈ Top 10% journal πŸ”— BMC biology Journal Article πŸ—“οΈ May 20

πŸ“Š IBD patients showed impaired memory and attention across 66 studies

  • Systematic review of 66 studies (31 population studies, 13 genetic studies, 22 preclinical studies) found that IBD patients exhibited impaired cognitive function, particularly in memory, attention, and executive processing
  • Disease activity, chronic inflammation, and psychological stress appeared to contribute to cognitive deficits
  • Some treatment strategies, particularly biologics, seemed to mitigate the risk of cognitive impairment, potentially through reducing neuroinflammation
πŸ’‘ Inflammatory bowel disease may increase dementia risk, but certain treatments could provide neuroprotective benefits.
πŸ₯‰ Top 5% journal πŸ”— Journal of Crohn's & colitis Systematic Review πŸ—“οΈ May 22

Implications

These studies reveal the gut-brain axis as a dynamic, bidirectional highway where specific bacteria and their metabolites can influence everything from Parkinson's progression to memory formation. The findings suggest that targeting gut microbiota could become a precision medicine approach for neurological and cognitive disorders, though sex differences and individual bacterial profiles may require personalized interventions.

Studies in this issue

Primary sources used for this newsletter.

  1. Stroke-related gut bacteria imbalance may speed up Alzheimer's disease
    main storyJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2026-05-20PMID 42157525
  2. Does Inflammatory Bowel Disease Relate to Memory and Thinking Decline? A Systematic Review
    key findingJournal of Crohn's & colitis2026-05-22PMID 42172661